Metabolic Outcomes of Surgery in Youth with Type 2 Diabetes
sciencedirect.com shows its articles on its own site.
Read the article on sciencedirect.com ↗Article · Feb 2020 · 1 min read
In brief
In brief
This review examines metabolic bariatric surgery as a treatment for youth-onset type 2 diabetes, which progresses more aggressively than adult-onset disease due to greater insulin resistance and rapid β-cell decline. Early surgical outcomes show high diabetes remission rates in adolescents, offering promise where medical management has shown limited success in halting disease progression.
Written by the GCMD Library team from the article.
Publication date: Available online 25 January 2020
Source: Seminars in Pediatric Surgery
Author(s): Amy S. Shah, Kristen J. Nadeau, Michael A. Helmrath, Thomas H. Inge, Stavra Xanthakos, Megan M. Kelsey
Abstract
Youth-onset type 2 diabetes (T2D) is a formidable threat to the health of obese adolescents because of its potential for early-onset and aggressive co-morbidities and complications. The physiology of youth-onset T2D differs from T2D in adults and is associated with a greater degree of insulin resistance, a more rapid decline in pancreatic β-cell function, and a poorer response to medications. Medical management in youth is focused on combining lifestyle intervention and pharmacological treatment, but these therapies have yet to demonstrate improvements in disease progression. Metabolic bariatric surgery (MBS) is now recommended for the treatment of T2D in adults largely because of the beneficial effects on weight, ability to improve glycemic control, and, in a large proportion of people, induce diabetes remission. MBS is now being performed in adolescents with severe obesity and T2D, with initial results also showing high rates of T2D remission. Here, we review the state of medical management of youth-onset T2D and the outcomes of MBS studies in youth with T2D published to date.